ACS Omega
(Sep 2024)
Two Different Responsive Organosilica Nanocarriers to Combine Chemo- and Immunotherapy against Cancer
- Maria Sancho-Albero,
- Alessia Lucrezia Fenaroli,
- Mirco Scaccaglia,
- Cristina Matteo,
- Chiara Grasselli,
- Massimo Zucchetti,
- Roberta Frapolli,
- Claudia Nastasi,
- Luisa De Cola
Affiliations
- Maria Sancho-Albero
- Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy
- Alessia Lucrezia Fenaroli
- Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy
- Mirco Scaccaglia
- Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy
- Cristina Matteo
- Department of Oncology, Laboratory of Cancer Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy
- Chiara Grasselli
- Department of Oncology, Immunopharmacology Unit, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy
- Massimo Zucchetti
- Department of Oncology, Laboratory of Cancer Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy
- Roberta Frapolli
- Department of Oncology, Laboratory of Cancer Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy
- Claudia Nastasi
- Department of Oncology, Immunopharmacology Unit, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy
- Luisa De Cola
- Department of Pharmaceutical Science, DISFARM, Università degli Studi di Milano, Milan, Italy
- DOI
-
https://doi.org/10.1021/acsomega.4c02838
- Journal volume & issue
-
Vol. 9,
no. 40
pp.
41225
– 41235
WeChat QR code
